ENTRY D06053 Drug NAME Teduglutide (USAN/INN); Teduglutide (genetical recombination) (JAN); Gattex (TN); Revestive (TN) PRODUCT GATTEX (Takeda Pharmaceuticals America) FORMULA C164H252N44O55S EXACT_MASS 3749.7995 MOL_WEIGHT 3752.08 SEQUENCE His Gly Asp Gly Ser Phe Ser Asp Glu Met Asn Thr Ile Leu Asp Asn Leu Ala Ala Arg Asp Phe Ile Asn Trp Leu Ile Gln Thr Lys Ile Thr Asp TYPE Peptide REMARK Therapeutic category: 2499 ATC code: A16AX08 Product: D06053 EFFICACY Mucosal growth promotor, Glucagon-like peptide 2 receptor agonist DISEASE Short bowel syndrome [DS:H01469] COMMENT Human glucagon-like peptide 2 (GLP-2) [CPD:C16049] analog Treatment of intestinal diseases characterized by chemical or surgical damage of the intestinal epithelium such as Short Bowel Syndrome (SBS) or damage to the intestinal epithelium due to disease TARGET GLP2R [HSA:9340] [KO:K04582] BRITE Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] A ALIMENTARY TRACT AND METABOLISM A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS A16AX Various alimentary tract and metabolism products A16AX08 Teduglutide D06053 Teduglutide (USAN/INN) <JP/US> USP drug classification [BR:br08302] Gastrointestinal Agents Gastrointestinal Agents, Other Teduglutide D06053 Teduglutide (USAN/INN) Therapeutic category of drugs in Japan [BR:br08301] 2 Agents affecting individual organs 24 Hormones 249 Miscellaneous 2499 Others D06053 Teduglutide (USAN/INN); Teduglutide (genetical recombination) (JAN) Target-based classification of drugs [BR:br08310] G Protein-coupled receptors Secretin receptor family Glucagon GLP2R D06053 Teduglutide (USAN/INN) <JP/US> New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D06053 New drug approvals in Europe [br08329.html] European public assessment reports (EPAR) authorised medicine D06053 New drug approvals in Japan [br08318.html] Drugs with new active ingredients D06053 New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D06053 DBLINKS CAS: 197922-42-2 PubChem: 47207711 ChEBI: 72305 ///